Phenytek Related Published Studies
Well-designed clinical trials related to Phenytek (Phenytoin)
Fosphenytoin for seizure prevention in childhood coma in Africa: a randomized
clinical trial. [2013]
The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial. [2011.10]
Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. [2011.07]
Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children. [2011.04.12]
Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. [2011.02]
Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures? [2010.10]
Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial. [2010.10]
Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. [2010.04]
Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study. [2010.03]
Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial. [2010.03]
Efficacy, tolerability, and safety of rapid initiation of topiramate versus
phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical
trial. [2010]
Early predisposition to osteomalacia in Indian adults on phenytoin or valproate
monotherapy and effective prophylaxis by simultaneous supplementation with
calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a
prospective study. [2010]
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. [2009.07]
Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. [2009.03.16]
Ineffectiveness of folic acid supplementation against phenytoin-induced decrease in salivary immunoglobulin A concentration of epileptic patients. [2008]
Topical phenytoin solution for treating pressure ulcers: a prospective, randomized, double-blind clinical trial. [2007.11]
Phenytoin as an augmentation for SSRI failures: a small controlled study. [2006.11]
Sodium valproate vs phenytoin in status epilepticus: a pilot study. [2006.07.25]
Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. [2006.06]
Oxcarbazepine versus phenytoin monotherapy for epilepsy. [2006.04.19]
Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. [2006]
[Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study] [2005.07]
Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder. [2005.05]
Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. [2005.03.01]
A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers [ISRCTN33429693]. [2004.12.15]
Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. [2004.12]
Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomized, double-blind, comparative study. [2004.09]
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. [2004.08.15]
Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure--a controlled clinical trial. [2004.07]
A randomized, double-blinded, placebo-controlled trial of phenytoin for the prevention of early posttraumatic seizures in children with moderate to severe blunt head injury. [2004.04]
A comparison of phenytoin-loading techniques in the emergency department. [2004.03]
Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department. [2004.03]
Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. [2003.12]
Prophylactic effect of phenytoin in bipolar disorder: a controlled study. [2003.12]
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers. [2003.12]
A randomized, crossover, assessor-blind study of the bioequivalence of a single oral dose of 200 mg of four formulations of phenytoin sodium in healthy, normal Indian volunteers. [2003.04]
Topical phenytoin versus EUSOL in the treatment of non-malignant chronic leg ulcers. [2003.03]
Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin. [2002.12]
Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration. [2002.12]
A comparison of topical Phenytoin with Silverex in the treatment of superficial dermal burn wounds. [2002.09]
Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects. [2002.09]
Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers. [2002.09]
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin. [2002.05]
Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. [2002.02]
Carbamazepine versus phenytoin monotherapy for epilepsy. [2002]
A double-blind placebo-controlled crossover study of phenytoin in individuals with impulsive aggression. [2001.09.20]
Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules. [2001.08.28]
Topical phenytoin treatment of stage II decubitus ulcers in the elderly. [2001.06]
Variability in the bioavailability of phenytoin capsules in males and females. [2001.03]
Fosphenytoin: pharmacokinetics and tolerance of intramuscular loading doses. [2001.02]
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. [2001]
Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood. [2000.12]
Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. [2000.09]
Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin. [2000.08]
Absorption of phenytoin from rectal suppositories formulated with a polyethylene glycol base. [2000.05]
Phenytoin as an antimanic anticonvulsant: a controlled study. [2000.03]
Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin. [1999.12]
[Clinical observation of phenytoin in promoting fracture healing] [1999.11]
Lack of pharmacokinetic interaction between grapefruit juice and phenytoin in healthy male volunteers and epileptic patients. [1999.11]
Efficacy of magnesium sulphate and phenytoin in the management of eclampsia. [1999.10]
Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. [1999.10]
Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis. [1999.10]
Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects. [1999.10]
Phenobarbital compared with phenytoin for the treatment of neonatal seizures. [1999.08.12]
Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. [1999.05]
Effects of phenytoin on cocaine self-administration in humans. [1999.02.01]
Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin. [1999.02]
Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo-controlled study in healthy volunteers. [1998.06]
Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings. [1998.05]
Induction of tirilazad clearance by phenytoin. [1998.03]
Phenytoin auto-induction. [1998.02]
Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study. [1998.01]
The effects of phenytoin on impulsive and premeditated aggression: a controlled study. [1997.10]
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. [1997.06]
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. [1997.06]
Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia. [1997.03]
Mutual interaction between remacemide hydrochloride and phenytoin. [1997.01]
[Effect of phenytoin and carbamazepine on evoked potentials in patients with newly diagnosed epilepsy. Part II. Brainstem auditory evoked potentials] [1996.11]
Early postoperative seizures and endovenous phenytoin. Preliminary clinical data. [1996.09]
A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus intravenous phenytoin (Dilantin) in hospital emergency departments. [1996.09]
Atovaquone has no effect on the pharmacokinetics of phenytoin in healthy male volunteers. [1996.08]
Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery. [1996.08]
Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study. [1996.07]
The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers. [1996.07]
The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients. [1996.07]
No influence of pantoprazole on the pharmacokinetics of phenytoin. [1996.05]
Phenytoin in the treatment of cocaine abuse: a double-blind study. [1996.04]
Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. [1996.03.16]
Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. [1996.02]
Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels. [1996]
Absence of a sertraline-mediated effect on digoxin pharmacokinetics and electrocardiographic findings. [1996]
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. [1995.12]
Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up. [1995.12]
A prospective, randomized trial of phenytoin in nonepileptic subjects with reduced HDL cholesterol. [1995.12]
Can phenytoin lower plasma fibrinogen concentrations? [1995.08.01]
Effects of phenytoin on plasma high-density lipoprotein cholesterol levels in men with low levels of high-density lipoprotein cholesterol. [1995.08]
Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. [1995.08]
A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. [1995.07.27]
Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. [1995.07]
No influence of pantoprazole on the pharmacokinetics of phenytoin. [1995.05]
Folic acid improves phenytoin pharmacokinetics. [1995.03]
|